{"name":"Claris Biotherapeutics, Inc.","slug":"claris-biotherapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNT0prd1BWcGg4OE00QXpzS2RDMWdmSzAyek5VelE3bkJvRFQ1SndVa1doQXhnVzY1Q2x2UEx6N2pLY1pZaFptMm1GQTRwMFZXQ0xXYngtYy1YV2l5WWJGRDVYMGZjdmZ0TGNxQjluX1NGaFBzOXgyUW9WYmVWakRXTENha1FZaGdYZmh2OG1NNnBOZlo3Z20xNA?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Neurotrophic Keratopathy Market: High-Growth Opportunities for Investors to 2034 - DelveInsight - openPR.com","headline":"Neurotrophic Keratopathy Market: High-Growth Opportunities for Investors to 2034 - DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOQ3dMUDJWMENrZjdsdVVUMWoyX2dCbzZPd01EMmVNdHdoMERlb05Hdk9UZWNwWXlLbTRXMzBPU0FMX3FuZXhKRUEzNmJsSTRSYjhObnJLR1VPMHRjMzlGV1BzV3JXZkVOS2hIdHU3alUwYmZGNUtZZFNfdkw0Y2tud21WOVBScGlUekxXQkllajRWMzFuOGJUTllWcVpqS05zdmZ3QXBkYmU4NjBGUDVtelJZYzRfT3BWTFQ0RnhPb0V5QWRTeFh5c0RaVmRLU2JyLTBmaW5xaDdiSWpGWk9tZ2c0MmJhMVI2VTFXam5WNGlGUG5NMVB3QXI4WXVIS2ZfNkQxZXRwc3EzQnFFbDQ5MDk4dnZqb1pOZEswTkI5c1RDRl9KLUc1Um1SaURSX2RKNEE?oc=5","date":"2026-02-02","type":"pipeline","source":"GlobeNewswire","summary":"Limbal Stem Cell Deficiency Market Set to Transform During - GlobeNewswire","headline":"Limbal Stem Cell Deficiency Market Set to Transform During","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOSW85MDFNTk9OQ2puNTlKalZHNlA2Q25NX0FqVXM3YTNJZXBKeTRIMWlZN2VnOVh5aVRqdmdBZk5zWUh1emMzUHhIeEJidTZ2Ul9QWHR0SXR4QVgyQS1zUUFJNEtCclh1RmczY0FTNWo5dGd3SFNpVG1CT0tERDZiUVJOOA?oc=5","date":"2025-07-15","type":"pipeline","source":"EyeWorld","summary":"The robust NK and PCED pharmaceutical pipeline - EyeWorld","headline":"The robust NK and PCED pharmaceutical pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQUlROaUdhVUlFQnR0REFFdmVvVU53Si1yZVQtQXB4MjF3cFlMTGJIWmlOQ2hNV1I2UzU4RXkxbFhOcjcyMWVULWNUWjIxbHJMVHgyN2Y0ajYxOE9lMmF1Y01NMTVYTEQwdXh2Wm9mcHJLdjlZVW5xMXkxNEJTd2NpamZMR09CMmFvckNBN0NUNFNLQUdwVmFxeDJkVjdIXzBiY013UExBUzNsYmx4MUJVcUEtQVVPd0JSM1hPcGpWOFpyT0U?oc=5","date":"2025-02-05","type":"pipeline","source":"Pharmacy Times","summary":"Examining an Important Orphan Disease: Neurotrophic Keratitis/Keratopathy and Its Treatment - Pharmacy Times","headline":"Examining an Important Orphan Disease: Neurotrophic Keratitis/Keratopathy and Its Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQMmIzcU9WUTVqR1VLRTZPSUlNRTdraTl2RDVJZ3BKbDdtNGs0YWlfRXZ4a2lGd0RjSFczWEdUQUg4MHRjTXpLWW5XRWxFTDRHdUdjQXNQTnl6cDloQ1F5OEpuNl82blAyX2ZXNTh6SC0xc09sTlF4czVaTmxIazBCaVRlRzdaZw?oc=5","date":"2024-03-19","type":"pipeline","source":"Bioprocess Online","summary":"Eying Up The ERA Of Topical Biologics - Bioprocess Online","headline":"Eying Up The ERA Of Topical Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxNNnBZOW9Vbm15ckZMOEpYSkN1aHNBdWdDeFF3OExXUWNEQjNUMmg4bmh0cm9MTDhMMG1BMnFLM0t5Z3daaGJDbTcxcHlsQVE2WTVHZVVLczlpeUgzUWQxb240YVdYOGg4WGFNc01tU0NUaHNCY3ljTWpjWHNFb19uSHE0MEE3LXo0eW9vQ2xSR1FuLV84cFZnUDhVWjR6WkgtWHdkWFE2aV9NOWZvQnQ0TzFWWUxSREpwU1hMVXNwR005SnFsWVVzT2FvNFhsT1RpOHVKejJIWU9ZNmpBbXBDSXNvZHd5M3JaUFJEbkJMN0NRVDNwUGIxUmVvcEpJWkxRQk10OEJ3NmtJVXlFY2VURW1XUVdfTUo3YjB1MkRQd19UWXY0QmY4OQ?oc=5","date":"2024-01-04","type":"pipeline","source":"GlobeNewswire","summary":"Claris Bio Emerges From Stealth With a New Investor and - GlobeNewswire","headline":"Claris Bio Emerges From Stealth With a New Investor and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxONjI2THYyOU9rbVhMMDRXU1JWNF9zcjRaT0R2TXR3SU5iQTktN1FYTlY1YzQzSkstRVFGZGxsOWg1RThVWENZTkRmemYyMEhBZzZFWUJZZ2h1YVJzN1NKaVpBSmMzWEU0TXlUbVhaZ0JtLTZDZmxiM1JEU1dBcU1PMg?oc=5","date":"2024-01-04","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}